IRON
Disc Medicine, Inc.
There isn't enough reported data to score IRON yet.
IRON Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
IRON's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
IRON PE Valuation
IRON has no meaningful PE right now: it lost money over the past year.
IRON Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect IRON's revenue to grow, with its earnings and profitability holding steady.
IRON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$6.36 | -$1.04 |
| Q2 2026 | -$6.60 | -$2.16 |
| Q1 2026 | -$6.64 | -$2.75 |
| Q4 2025 | -$6.01 | -$2.05 |
| Q3 2025 | -$5.32 | -$1.41 |
| Q2 2025 | -$4.44 | -$0.84 |
| Q1 2025 | -$3.89 | -$0.58 |
| Q4 2024 | -$3.96 | -$0.54 |
IRON is still losing money, but far less than before: $6.36 per share over the past year, against $50.36 at its worst in late 2022.
IRON Quarterly Revenue
IRON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$40.2M | +$7.6M |
| Q2 2026 | -$44.2M | +$3.8M |
| Q1 2026 | -$62.2M | -$20M |
| Q4 2025 | -$43.3M | -$15.3M |
| Q3 2025 | -$47.8M | -$30.5M |
| Q2 2025 | -$48M | -$32.6M |
| Q1 2025 | -$42.2M | -$8.6M |
| Q4 2024 | -$28M | -$10.2M |
IRON has burned cash in almost every quarter: −$190M over the past year, against −$166M the year before.
IRON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +219K shares |
| 1 year | +11% | +3.7M shares |
| 3 years | +81% | +17.4M shares |
| 5 years | +1115% | +35.7M shares |
IRON has 39M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
IRON Net Leverage
IRON's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IRON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.8 | Neutral |
| Stochastic | 84.2 | Overbought |
IRON's weekly RSI is 61 (neutral) and its Stochastic is 84 (overbought).
IRON PE vs Healthcare Sector
IRON has no meaningful PE right now: it lost money over the past year.
IRON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $70.8 | 18% above |
| 20 week MA | $74.1 | 12% above |
| 50 week MA | $72.1 | 16% above |
| 100 week MA | $66.0 | 26% above |
| 200 week MA | $55.9 | 49% above |
IRON is in an uptrend: it's above all five of its weekly moving averages, and 49% above its 200-week average.
IRON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $104.4 | $105.0 | +0.6% |
| 2021 | $105.0 | $29.1 | -72% |
| 2022 | $29.1 | $15.5 | -47% |
| 2023 | $15.5 | $57.8 | +273% |
| 2024 | $57.8 | $64.1 | +11% |
| 2025 | $64.1 | $80.3 | +25% |
| 2026 YTD | $80.3 | $83.2 | +3.6% |
IRON's yearly returns have swung widely, from +273% in 2023 to −72% in 2021. It's up 3.6% so far in 2026.